Mirabella (Ethinylestradiol, Gestodene)

Ethinylestradiol and Gestodene, the active ingredients in Mirabella, are a combined oral contraceptive presented as a tablet for oral use. They are prescribed to prevent pregnancy and may also be used to manage certain menstrual disorders in women of reproductive age.

GNH USA supplies Mirabella as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Mirabella, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent ovulation.

- Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. - Acne treatment: reduces androgen‑driven acne lesions in women. - Menstrual disorder management: helps regulate menstrual cycles and relieve dysmenorrhea.

Mirabella may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: transient swelling or discomfort. - Irregular bleeding: spotting or breakthrough bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty.

Before prescribing Mirabella, consider the following precautions to ensure safe use.

- Cardiovascular risk assessment: evaluate history of thromboembolic disorders before use. - Smoking status: avoid in women over 35 who smoke. - Liver function: monitor in patients with hepatic impairment. - Medication review: assess concomitant use of drugs that affect coagulation. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Mirabella can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may reduce anticoagulant effect. - Antiepileptics (e.g., phenytoin, carbamazepine): may lower contraceptive efficacy. - Rifampicin: induces metabolism, decreasing hormone levels.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole): can increase hormone concentrations. - St. John’s wort: may reduce effectiveness through enzyme induction. - Certain antibiotics (e.g., tetracycline): may slightly diminish contraceptive reliability.